UB Paderborn / Katalog / Suche / in CDI

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

Clinical microbiology and infection, 2018-06, Vol.24, p.S71-S82

2018

Volltextzugriff (PDF)

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

Clinical microbiology and infection, 2018-06, Vol.24, p.S83-S94

2018

Volltextzugriff (PDF)

Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species

European journal of clinical microbiology & infectious diseases, 2014-01, Vol.33 (1), p.7-21

2014

Volltextzugriff (PDF)

A Randomized, Blinded, Multicenter Trial of Lipid-Associated Amphotericin B Alone versus in Combination with an Antibody-Based Inhibitor of Heat Shock Protein 90 in Patients with Invasive Candidiasis

Clinical infectious diseases, 2006-05, Vol.42 (10), p.1404-1413

2006

Volltextzugriff (PDF)

Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observed In Clinical Practice

Value in health, 2014-11, Vol.17 (7), p.A657-A658

2014

Volltextzugriff (PDF)

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

Journal of antimicrobial chemotherapy, 2011-01, Vol.66 Suppl 1 (Supplement 1), p.i5-i14

2011

Volltextzugriff (PDF)

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study

Supportive care in cancer, 2006-03, Vol.14 (3), p.285-290

2006

Volltextzugriff (PDF)

Clinical analysis of 92 patients with Fungaemia - data from national survey in Slovakia

International journal of infectious diseases, 2010, Vol.14, p.e125-e126

2010

Volltextzugriff (PDF)

Tandem autologous stem cell transplantation in multiple myeloma after high-dose chemotherapy with two separate collections: single institution experience

Neoplasma, 2012, Vol.59 (5), p.551

2012

Volltextzugriff (PDF)

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

Clinical microbiology and infection, 2018-06, Vol.24, p.S53-S70

2018

Volltextzugriff (PDF)

The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information

Clinical microbiology and infection, 2018-02, Vol.24 (2), p.105-109

2018

Volltextzugriff (PDF)

Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2020-03, Vol.64 (4)

2020

Volltextzugriff (PDF)

Triggers for driving treatment of at-risk patients with invasive fungal disease

Journal of antimicrobial chemotherapy, 2013-11, Vol.68 Suppl 3 (suppl 3), p.iii17-iii24

2013

Volltextzugriff (PDF)

Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin

Neoplasma, 2007, Vol.54 (5), p.424

2007

Volltextzugriff (PDF)

PCN245 - Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observed In Clinical Practice

Value in health, 2014-11, Vol.17 (7), p.A657-A658

2014

Volltextzugriff (PDF)

Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients

Clinical microbiology and infection, 2006-03, Vol.12 (3), p.212-216

2006

Volltextzugriff (PDF)

Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin

European journal of clinical microbiology & infectious diseases, 1996-03, Vol.15 (3), p.259-261

1996

Volltextzugriff (PDF)

Risk Factors, Aetiology, Therapy and Outcome in 123 Episodes of Breakthrough Bacteraemia and Fungaemia during Antimicrobial Prophylaxis and Therapy in Cancer Patients

Journal of medical microbiology, 1997-06, Vol.46 (6), p.517-523

1997

Volltextzugriff (PDF)

Treatment of invasive mycotic infections in patients with an altered immune status--guidelines of expert associations

Vnitřní lékar̆stvĭ, 2008-12, Vol.54 (12), p.1171-1173

2008

Volltextzugriff (PDF)

Funguria in cancer patients : Analysis of risk factors, clinical presentation and outcome in 50 patients

Infection, 1996-07, Vol.24 (4), p.319-323

1996

Volltextzugriff (PDF)

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I

Neoplasma, 2005, Vol.52 (2), p.159

2005

Volltextzugriff (PDF)

Use of selected CD34+ cells in the treatment of relapsed/progressive HD: experiences from a single center

Cytotherapy (Oxford, England), 2002-03, Vol.4 (2), p.177-180

2002

Volltextzugriff (PDF)

Bacteremia and Fungemia Occurring during Antimicrobial Prophylaxis with Ofloxacin in Cancer Patients: Risk Factors, Etiology and Outcome

Journal of chemotherapy (Florence), 1996-10, Vol.8 (5), p.387-393

1996

Volltextzugriff (PDF)

Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome

Bratislavské lékarské listy, 1996-11, Vol.97 (11), p.647

1996

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species

A Randomized, Blinded, Multicenter Trial of Lipid-Associated Amphotericin B Alone versus in Combination with an Antibody-Based Inhibitor of Heat Shock Protein 90 in Patients with Invasive Candidiasis

Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observed In Clinical Practice

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study

Clinical analysis of 92 patients with Fungaemia - data from national survey in Slovakia

Tandem autologous stem cell transplantation in multiple myeloma after high-dose chemotherapy with two separate collections: single institution experience

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa

Triggers for driving treatment of at-risk patients with invasive fungal disease

Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin

PCN245 - Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observed In Clinical Practice

Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients

Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin

Risk Factors, Aetiology, Therapy and Outcome in 123 Episodes of Breakthrough Bacteraemia and Fungaemia during Antimicrobial Prophylaxis and Therapy in Cancer Patients

Treatment of invasive mycotic infections in patients with an altered immune status--guidelines of expert associations

Funguria in cancer patients : Analysis of risk factors, clinical presentation and outcome in 50 patients

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I

Use of selected CD34+ cells in the treatment of relapsed/progressive HD: experiences from a single center

Bacteremia and Fungemia Occurring during Antimicrobial Prophylaxis with Ofloxacin in Cancer Patients: Risk Factors, Etiology and Outcome

Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome

Suchergebnisse filtern